VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

Status:
Completed

Trial end date:
2006-08-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

Phase 3

Vanda Pharmaceuticals